HARVARD BIOSCIENCE INC Share Price Today: Live Updates & Key Insights

HARVARD BIOSCIENCE INC share price today is $5.915, up -3.07%. The stock opened at $6.08 against the previous close of $6.19, with an intraday high of $6.08 and low of $6.03.

HARVARD BIOSCIENCE INC Share Price Chart

HARVARD BIOSCIENCE INC

us-stock
To Invest in {{usstockname}}
us-stock

HARVARD BIOSCIENCE INC Share Price Performance

$5.915 -0.0307(-3.07%) HBIO at 27 Jul 2026 03:25 PM Medical Instruments & Supplies
Lowest Today 6.03
Highest Today 6.08
Today’s Open 6.08
Prev. Close 6.19
52 Week High 9.40
52 Week Low 3.76
Day’s Range: Low 6.03 High 6.08
52-Week Range: Low 3.76 High 9.40
1 day return -
1 Week return +1.8
1 month return +1.97
3 month return -9.48
6 month return +968.78
1 year return +1059.52
3 year return +29.3
5 year return -20.51
10 year return -

HARVARD BIOSCIENCE INC Institutional Holdings

Weber Capital Management LLC 7.10

Vanguard Group Inc 4.26

Acadian Asset Management LLC 3.98

Vanguard Capital Management, LLC 3.62

Corsair Capital Management LLC 2.77

Vanguard Total Stock Mkt Idx Inv 2.74

Meros Investment Management, LP 2.63

NANO CAP NEW MILLENNIUM GROWTH FUND L P 2.61

Two Sigma Investments LLC 2.53

Acuitas US Microcap Strategy 2.27

Renaissance Technologies Corp 2.25

Two Sigma Advisers, LLC 1.95

BlackRock Inc 1.38

Geode Capital Management, LLC 1.32

Millennium Management LLC 1.03

Vanguard Institutional Extnd Mkt Idx Tr 0.93

Fidelity Extended Market Index 0.62

Vanguard Fiduciary Trust Co 0.61

Essex Investment Management Company, LLC 0.60

Jane Street Group LLC 0.53

Williams & Novak LLC 0.46

RBF LLC 0.35

State Street Corp 0.33

Bank of New York Mellon Corp 0.23

Acuitas US Microcap Institutional 0.19

Blackrock Extended Mkt Fund CF 0.17

Extended Equity Market Fund B 0.17

Extended Equity Market Fund E 0.17

Spartan Extended Market Index Pool F 0.16

Fidelity Total Market Index 0.16

BlackRock Extended Equity Market Fund K 0.15

Stewardship Partners US Multi Tax-Eff 0.14

Fidelity Series Total Market Index 0.13

Northern Trust Extended Eq Market Idx 0.10

NT Ext Equity Mkt Index Fund - Lending 0.10

NT Ext Equity Mkt Index Fund - NL 0.10

Essex Inv Mgt Micro Cap Growth 0.10

Vanguard Balanced Index Inv 0.09

Gabelli Global Mini Mites I 0.09

SSgA U.S. Total Market Index Strategy 0.01

HARVARD BIOSCIENCE INC Market Status

Strong Buy: 0

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

HARVARD BIOSCIENCE INC Fundamentals

Market Cap 27.92 M

PB Ratio 2.7521

PE Ratio 0.0

Enterprise Value 64.67 M

Total Assets 80.07 M

Volume 6032

HARVARD BIOSCIENCE INC Company Financials

Annual Revenue FY23:112524000 112.5M, FY22:113335000 113.3M, FY21:118904000 118.9M, FY20:102100000 102.1M, FY19:116176000 116.2M

Annual Profit FY23:65579000 65.6M, FY22:60819000 60.8M, FY21:67652000 67.7M, FY20:58041000 58.0M, FY19:64322000 64.3M

Annual Net worth FY23:-3263000 -3.3M, FY22:-9516000 -9.5M, FY21:-288000 -0.3M, FY20:-7810000 -7.8M, FY19:-4687000 -4.7M

Quarterly Revenue Q1/2026:20755000 20.8M, Q3/2025:20591000 20.6M, Q2/2025:20450000 20.5M, Q1/2025:21774000 21.8M, Q3/2024:21970000 22.0M

Quarterly Profit Q1/2026:12244000 12.2M, Q3/2025:12021000 12.0M, Q2/2025:10371000 10.4M, Q1/2025:12184000 12.2M, Q3/2024:12765000 12.8M

Quarterly Net worth Q1/2026:-3424000 -3.4M, Q3/2025:-1231000 -1.2M, Q2/2025:-2282000 -2.3M, Q1/2025:-50340000 -50.3M, Q3/2024:-4802000 -4.8M

About HARVARD BIOSCIENCE INC & investment objective

Company Information Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Organisation Medical Instruments & Supplies

Employees 316

Industry Medical Instruments & Supplies

CEO Mr. John Duke

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

HARVARD BIOSCIENCE INC FAQs

What is the share price of HARVARD BIOSCIENCE INC today?

The current share price of HARVARD BIOSCIENCE INC is $5.915.

Can I buy HARVARD BIOSCIENCE INC shares in India?

Yes, Indian investors can buy HARVARD BIOSCIENCE INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy HARVARD BIOSCIENCE INC shares in India?

You can easily invest in HARVARD BIOSCIENCE INC shares from India by:

Can I buy fractional shares of HARVARD BIOSCIENCE INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of HARVARD BIOSCIENCE INC?

HARVARD BIOSCIENCE INC has a market cap of $27.92 M.

In which sector does HARVARD BIOSCIENCE INC belong?

HARVARD BIOSCIENCE INC operates in the Medical Instruments & Supplies sector.

What documents are required to invest in HARVARD BIOSCIENCE INC stocks?

To invest, you typically need:

What is the PE and PB ratio of HARVARD BIOSCIENCE INC?

The PE ratio of HARVARD BIOSCIENCE INC is N/A and the PB ratio is 2.75.